3D Optical Coherence Tomography 3D OCT-1 (Maestro2)

The 3D OCT-1 (Maestro2) is designed to capture high-resolution, cross-sectional images of the retina, enabling detailed volumetric scans of ocular tissues. It is specifically used to assess retinal structure and detect abnormalities such as macular degeneration, diabetic retinopathy, or glaucoma. The device achieves this through optical coherence tomography (OCT), a non-invasive imaging technique that provides precise, layer-by-layer visualization of retinal layers, aiding in early detection and monitoring of these conditions.

No, the 3D OCT-1 (Maestro2) is explicitly designed for **single-use only** in clinical or ophthalmology settings, as indicated by its non-reusable classification. This means each device is intended for one procedure or diagnostic session before disposal. Clinicians must follow the manufacturer’s instructions for proper handling to ensure safety and compliance, including avoiding reuse or reprocessing, which could compromise sterility or performance.

Since the 3D OCT-1 (Maestro2) is **non-sterile**, it does not require sterile storage conditions like surgical instruments. However, the manufacturer’s instructions must be followed for optimal performance and longevity. This typically includes protecting the device from physical damage, extreme temperatures, humidity, or contamination. Proper storage ensures the device remains functional for its intended single-use session while maintaining traceability via its UDI (e.g., B-04562123289213).

The 3D OCT-1 (Maestro2) has been authorized under **FDA 510K**, **MDD (Medical Device Directive)**, and **MDR (Medical Device Regulation)** pathways, confirming compliance with U.S., European, and global medical device standards. These approvals ensure the device meets stringent safety, performance, and quality requirements for diagnostic imaging in ophthalmology. Clinicians or purchasers can rely on these regulatory clearances to validate its suitability for clinical use in markets where these standards apply.

The device is listed under the **Maestro2 model**, with no additional sizes or variants specified in the provided data. This suggests it is a singular, standardized system for high-resolution retinal imaging, designed to meet general clinical needs for diagnosing retinal diseases like macular degeneration or glaucoma. While not customizable for different patient sizes, its advanced imaging capabilities ensure versatility across various ophthalmology settings, from private practices to hospitals.